$43.140
+0.375 (+0.87%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
First Tracks Biotherapeutics Inc (TRAX) Moving Averages Convergence Divergence (MACD) indicator is 0.66, suggesting TRAX is Strong buy.
First Tracks Biotherapeutics Inc (TRAX) 20-Day simple moving average is 35.12, while First Tracks Biotherapeutics Inc (TRAX) share price is $—, making it Buy.
First Tracks Biotherapeutics Inc (TRAX) 60-Day simple moving average is 40.04, while First Tracks Biotherapeutics Inc (TRAX) share price is $—, making it Buy.
Technical Analysis for TRAX
AI Technical TRAXAs of 2026-10-17, the technical board for First Tracks Biotherapeutics Inc (TRAX) reads strong buy: 9 indicators are flashing buy, 2 are indicating sell, and 2 are neutral. Price at $43.14 sits above every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 64.704, MACD stands at 0.664 (Buy), Stochastic %K stands at 95.797 (Sell), Stochastic %D stands at 82.001 and CCI stands at 220.866 (Sell).
TRAX trades above the 60-day SMA (40.04) and above the 200-day SMA (30.38). Immediate resistance sits at Classic R1 43.57, then R2 50.57. Support sits at Classic S1 30.14, then S2 23.71.
First Tracks Biotherapeutics Inc (TRAX) Support & Resistance Level
First Tracks Biotherapeutics Inc (TRAX) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 64.704 |
| STOCHk_14_3_3 | 95.797 |
| STOCHd_14_3_3 | 82.001 |
| CCI_20 | 220.866 |
| AO_5_34 | 2.139 |
| MOM_10 | 11.130 |
| MACD_12_26_9 | 0.664 |
First Tracks Biotherapeutics Inc (TRAX) Relative Strength Index (RSI_14) is 64.704, creating a Neutral signal.
First Tracks Biotherapeutics Inc (TRAX) Stochastic %K is 95.797, creating a Sell signal.
First Tracks Biotherapeutics Inc (TRAX) Stochastic %D is 82.001, creating a Sell signal.
First Tracks Biotherapeutics Inc (TRAX) CCI_20 is 220.866, creating a Sell signal.
First Tracks Biotherapeutics Inc (TRAX) Awesome Oscillator (AO) is 2.139, creating a Buy signal.
First Tracks Biotherapeutics Inc (TRAX) Momentum (MOM) is 11.130, creating a Buy signal.
First Tracks Biotherapeutics Inc (TRAX) Moving Average Convergence Divergence (MACD) is 0.664, creating a Buy signal.
First Tracks Biotherapeutics Inc (TRAX) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 39.580 | Buy |
| MA_10 | 36.565 | Buy |
| MA_20 | 35.116 | Buy |
| MA_60 | 40.039 | Buy |
| MA_200 | 30.379 | Buy |
| MA_250 | 30.379 | Buy |
First Tracks Biotherapeutics Inc (TRAX) 5-Day simple moving average is 39.580, while First Tracks Biotherapeutics Inc (TRAX) share price is $, making it a Buy.
First Tracks Biotherapeutics Inc (TRAX) 10-Day simple moving average is 36.565, while First Tracks Biotherapeutics Inc (TRAX) share price is $, making it a Buy.
First Tracks Biotherapeutics Inc (TRAX) 20-Day simple moving average is 35.116, while First Tracks Biotherapeutics Inc (TRAX) share price is $, making it a Buy.
First Tracks Biotherapeutics Inc (TRAX) 60-Day simple moving average is 40.039, while First Tracks Biotherapeutics Inc (TRAX) share price is $, making it a Buy.
First Tracks Biotherapeutics Inc (TRAX) 200-Day simple moving average is 30.379, while First Tracks Biotherapeutics Inc (TRAX) share price is $, making it a Buy.
First Tracks Biotherapeutics Inc (TRAX) 250-Day simple moving average is 30.379, while First Tracks Biotherapeutics Inc (TRAX) share price is $, making it a Buy.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.